N.B. This English text is an unofficial translation of the Swedish original of the notice to attend the annual general meeting. In case of any discrepancies between the Swedish and English language versions, the Swedish version shall prevail
Notice
Shareholders wishing to participate at the meeting must:
(i) be entered in the shareholders' register, kept by
(ii) notify the Company of their attendance and any assistant no later than
Notification shall include full name, personal identification number or corporate registration number, address and daytime telephone number and, where applicable, information about representative, proxy and assistants. The number of assistants may not be more than two. In order to facilitate entry to the meeting, notification should, where applicable, be accompanied by powers of attorney, registration certificates and other documents of authority.
Personal data collected from the register of shareholders kept by
Nominee registered shares
Shareholders who have their shares registered in the name of a nominee must request temporary entry in the transcription of the share register kept by
Proxy and power of attorney forms
A shareholder represented by proxy shall issue a power of attorney which shall be dated and signed by the shareholder. If issued by a legal entity, the power of attorney shall be accompanied by registration certificate or, if not applicable, equivalent documents of authority. Power of attorney forms for those shareholders wishing to participate by proxy are available on the Company's website www.indexpharma.com. The original version of the power of attorney shall also be presented at the meeting.
Proposed Agenda
- Opening of the meeting and election of chairman of the meeting;
- Preparation and approval of the voting list;
- Approval of the agenda;
- Election of at least one person who shall approve the minutes of the meeting;
- Determination of whether the meeting has been duly convened;
- Presentation of the annual report and the auditor's report as well as of the consolidated financial statements and the auditor's report for the group. In connection with this:
- a presentation of the past year's work by the Board;
- a presentation by the Chief Executive Officer; and
- an update regarding the evaluation of alternatives to maximize shareholder value;
- Resolution in respect of:
- adoption of the profit and loss statement and the balance sheet as well as of the consolidated profit and loss statement and the consolidated balance sheet for the group;
- allocation of the Company's profits or losses according to the adopted balance sheet; and
- the members of the board of directors' and the CEO's discharge from liability;
- Determination of the number of members of the board of directors, and if applicable deputy members of the board of directors, as well as of the number of auditors, and if applicable deputy auditors;
- Determination of the fees payable to the members of the board of directors and the auditor;
- Election of members of the board of directors and auditor; and
- Closing of the meeting.
Proposed resolutions presented by the board of directors
Item 1: Election of chairman of the meeting
The board of directors proposes that attorney at law Marcus Nivinger is elected chairman of the meeting.
Item 7b): Resolution in respect of allocation of the Company's profits or losses
The board of directors proposes that the Company's accumulated profits shall be carried forward in new account and that no dividend shall be paid for the financial year 2023.
Item 8: Determination of the number of members of the board of directors, as well as of the number of auditors
The board of directors currently consists of the following six ordinary members without deputy members:
The board of directors proposes that unchanged fees to the board of directors, until the end of the next annual general meeting, shall amount to
Item 10: Election of members of the board of directors and auditor
The board of directors proposes re-election of
Karl Tobieson is CEO of
The auditing company
Number of shares and votes in the Company
The total number of shares in the Company at the time of issuance of this notice is 532,687,650. The Company does not hold any of its own shares.
Shareholders' right to request information
Pursuant to Chapter 7 section 32 of the Swedish Companies Act (Sw. aktiebolagslagen (2005:551)) the board of directors and the CEO are under a duty to, if any shareholder so requests and the board of directors believe that it can be done without material damage to the Company, provide information at the meeting regarding circumstances that may affect the assessment of an item on the agenda or of the Company's economic situation. Such duty to provide information also comprises the Company's relation to the other group companies, the consolidated financial statements and such circumstances regarding subsidiaries which are set out in the foregoing sentence.
Documentation
The financial accounts, auditor's report, complete proposals and other documents to be dealt with at the general meeting will be kept available at the Company's office not later than three weeks before the meeting. The documents will be sent free of charge to shareholders who so request and state their postal address. The documents will also be made available not later than the aforementioned date on the Company's website www.indexpharma.com. All the above mentioned documents will also be presented at the general meeting.
________________
The Board of Directors
Offical version of notice to attend the Annual General Meeting
The official version of the notice to attend the Annual General Meeting is in the Swedish language and available for download at www.indexpharma.com
For more information:
Phone: +46 8 122 038 50
E-post: jenny.sundqvist@indexpharma.com
Johan Giléus, CFO and Deputy CEO
Phone: +46 8 122 038 50
E-mail: johan.gileus@indexpharma.com
Publication
The information was submitted for publication through the agency of the contact person set out above at
InDex is based in
https://news.cision.com/index-pharmaceuticals/r/notice-of-annual-general-meeting-in-index-pharmaceuticals-holding-ab--publ-,c3956815
https://mb.cision.com/Main/9612/3956815/2712738.pdf
(c) 2024 Cision. All rights reserved., source